Upcoming Conference – Extracellular Vesicles – Biomarkers, Drug Delivery and Therapeutics

Hear Presentations from 2018’s Top 3, Most Richly Funded Exosome Startups:

Codiak Biosciences – Total Funding of $168.5 Million
Raghu Kalluri, MD, PhD, Professor & Chair, University of Texas MD Anderson Cancer Center, Director & Scientific Co-Founder, Codiak

Exosome Diagnostics – Total Funding of $112 Million
Johan Skog, PhD, CSO, Exosome Diagnostics

Evox Therapeutics – Total Funding of $59.5 Million
Per Lundin, PhD, MBA, Co-Founder & Chief Operating Officer, Evox Therapeutics Ltd.      

View all speaker biographies here.